Alzai Health Corp. (TSXV:ALZI)
0.4500
-0.0200 (-4.26%)
Jul 3, 2026, 1:04 PM EST
Alzai Health Company Description
Alzai Health Corp., a healthcare technology company, provides artificial intelligence driven solution for risk screening.
The company offers risk screening solutions for Mild Cognitive Impairment, Alzheimer’s Disease, and Related Dementias.
The company’s Alzai Risk Screening Solution offers prevention strategies, timely intervention and diagnosis of diseases.
It caters to various markets including healthcare providers and payors, pharmaceutical companies, research organizations, and research sites, clinical trials and research companies, and public health and private insurers.
The company was incorporated in 2024 and is based in Toronto, Canada.
Alzai Health Corp.
| Country | Canada |
| Founded | 2024 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Hayim Raclaw |
Contact Details
Address: 22 Adelaide Street West Toronto, ON M5H 4E3 Canada | |
| Phone | (416) 862-4351 |
| Website | alzaihealth.com |
Stock Details
| Ticker Symbol | ALZI |
| Exchange | TSX Venture Exchange |
| Fiscal Year | May - April |
| Reporting Currency | CAD |
| SIC Code | 8099 |
Key Executives
| Name | Position |
|---|---|
| Hayim Raclaw | Co-Founder, Chairman and Chief Executive Officer |
| Roy Kait | Co-Founder, Chief Revenue Officer and Director |
| Dr. Amir Glik M.D. | Co-Founder, Chief Medical Officer and Director |
| Dr. Chen Hajaj | Co-Founder and Head of Data Science |
| Dr. Anat Goldstein | Co-Founder and AI Expert |
| Ofri Kait | Co-Founder, Director of Business Development and Operations |
| Israel Messer | Chief Financial Officer and Corporate Secretary |